Legal Representation
Attorney
Martin L. Katz
USPTO Deadlines
Application History
23 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 15, 2005 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Jul 15, 2005 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
Dec 15, 2004 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
Dec 14, 2004 | CNFR | W | SU - FINAL REFUSAL - WRITTEN | Loading... |
Dec 2, 2004 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
Nov 22, 2004 | I | PAPER RECEIVED | Loading... | |
Nov 22, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 5, 2004 | FAXX | I | FAX RECEIVED | Loading... |
Oct 4, 2004 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
Oct 4, 2004 | CNRT | O | NON-FINAL ACTION MAILED | Loading... |
Sep 30, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 28, 2004 | FAXX | I | FAX RECEIVED | Loading... |
Sep 28, 2004 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Sep 3, 2004 | I | PAPER RECEIVED | Loading... | |
Sep 3, 2004 | IUAF | S | USE AMENDMENT FILED | Loading... |
Jun 15, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Mar 23, 2004 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 3, 2004 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Jan 21, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Dec 22, 2003 | I | PAPER RECEIVED | Loading... | |
Dec 22, 2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 26, 2003 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
Sep 24, 2003 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF CARDIOVASCULAR, VASCULAR AND RELATED INFLAMMATORY DISEASES
First Use Anywhere:
May 16, 2003
First Use in Commerce:
May 16, 2003
Additional Information
Pseudo Mark
INCISIVE PHARMACEUTICALS
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"pharmaceuticals"